APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceutical Transport Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Radiopharmaceutical Transport Service Market Outlook and Growth Opportunities 2026

3 July 2026204 pages

Choose your research edition.

Industry ResearchRadiopharmaceutical Transport Service Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceutical Transport Service Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Radiopharmaceutical Transport Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceutical Transport Service Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceutical Transport Service Market Analysis and Forecast 2026-2032185 pages · $4,950 USD

Market perspective

The global Radiopharmaceutical Transport Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Radiopharmaceutical Transport Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Radiopharmaceutical Transport Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Radiopharmaceutical Transport Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Radiopharmaceutical Transport Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Radiopharmaceutical Transport Service market include AirNet II, Circle Express, Life Couriers, MNX Global Logistics, Kalitta Charters, Perlamar Ltd, Isotopes, Global Airfreight International and Ameriflight, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Radiopharmaceutical Transport Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Radiopharmaceutical Transport Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Radiopharmaceutical Transport Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Radiopharmaceutical Transport Service market.

Radiopharmaceutical Transport Service Segment by Company

AirNet II

Circle Express

Life Couriers

MNX Global Logistics

Kalitta Charters

Perlamar Ltd

Isotopes

Global Airfreight International

Ameriflight

SWAN Isotopen AG

Medi-Ops

Crisago

Yantai Dalong Logistics Co., Ltd.

Sinotau Pharmaceutical Group

Ichimiya Transport

Transnuclear

SK Group

Radiopharmaceutical Transport Service Segment by Type

Short-half-life Radionuclide Transport

Long-half-life Radionuclide Transport

Radiopharmaceutical Transport Service Segment by Application

Radiopharmaceutical Manufacturers

Hospitals and Medical Institutions

Others

Radiopharmaceutical Transport Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Radiopharmaceutical Transport Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Radiopharmaceutical Transport Service key companies, revenue, market share, and recent developments.

3. To split the Radiopharmaceutical Transport Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Radiopharmaceutical Transport Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Radiopharmaceutical Transport Service significant trends, drivers, influence factors in global and regions.

6. To analyze Radiopharmaceutical Transport Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical Transport Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical Transport Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical Transport Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radiopharmaceutical Transport Service industry.

Chapter 3: Detailed analysis of Radiopharmaceutical Transport Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Radiopharmaceutical Transport Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Radiopharmaceutical Transport Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Radiopharmaceutical Transport Service Industry Trends Table 2. Radiopharmaceutical Transport Service Industry Drivers Table 3. Radiopharmaceutical Transport Service Industry Opportunities and Challenges Table 4. Radiopharmaceutical Transport Service Industry Restraints Table 5. Global Radiopharmaceutical Transport Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Radiopharmaceutical Transport Service Revenue Share by Company (2021-2026) Table 7. Global Radiopharmaceutical Transport Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Radiopharmaceutical Transport Service Key Company Manufacturing Base & Headquarters Table 9. Global Radiopharmaceutical Transport Service Company, Product Type & Application Table 10. Global Radiopharmaceutical Transport Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Radiopharmaceutical Transport Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Short-half-life Radionuclide Transport Table 15. Significant Companies of Long-half-life Radionuclide Transport Table 16. Global Radiopharmaceutical Transport Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Radiopharmaceutical Transport Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Radiopharmaceutical Transport Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Radiopharmaceutical Transport Service Sales Value Share by Type (2021-2026) Table 20. Global Radiopharmaceutical Transport Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Radiopharmaceutical Manufacturers Table 22. Significant Companies of Hospitals and Medical Institutions Table 23. Significant Companies of Others Table 24. Global Radiopharmaceutical Transport Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Radiopharmaceutical Transport Service Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Radiopharmaceutical Transport Service Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Radiopharmaceutical Transport Service Sales Value Share by Application (2021-2026) Table 28. Global Radiopharmaceutical Transport Service Sales Value Share by Application (2027-2032) Table 29. Global Radiopharmaceutical Transport Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Radiopharmaceutical Transport Service Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Radiopharmaceutical Transport Service Sales Value Share by Region (2021-2026) Table 32. Global Radiopharmaceutical Transport Service Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Radiopharmaceutical Transport Service Sales Value Share by Region (2027-2032) Table 34. Global Radiopharmaceutical Transport Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Radiopharmaceutical Transport Service Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Radiopharmaceutical Transport Service Sales Value Market Share by Country (2021-2026) Table 37. Global Radiopharmaceutical Transport Service Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Radiopharmaceutical Transport Service Sales Value Market Share by Country (2027-2032) Table 39. AirNet II Company Information Table 40. AirNet II Business Overview Table 41. AirNet II Radiopharmaceutical Transport Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. AirNet II Radiopharmaceutical Transport Service Product Portfolio Table 43. AirNet II Recent Development Table 44. Circle Express Company Information Table 45. Circle Express Business Overview Table 46. Circle Express Radiopharmaceutical Transport Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Circle Express Radiopharmaceutical Transport Service Product Portfolio Table 48. Circle Express Recent Development Table 49. Life Couriers Company Information Table 50. Life Couriers Business Overview Table 51. Life Couriers Radiopharmaceutical Transport Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Life Couriers Radiopharmaceutical Transport Service Product Portfolio Table 53. Life Couriers Recent Development Table 54. MNX Global Logistics Company Information Table 55. MNX Global Logistics Business Overview Table 56. MNX Global Logistics Radiopharmaceutical Transport Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. MNX Global Logistics Radiopharmaceutical Transport Service Product Portfolio Table 58. MNX Global Logistics Recent Development Table 59. Kalitta Charters Company Information Table 60. Kalitta Charters Business Overview Table 61. Kalitta Charters Radiopharmaceutical Transport Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Kalitta Charters Radiopharmaceutical Transport Service Product Portfolio Table 63. Kalitta Charters Recent Development Table 64. Perlamar Ltd Company Information Table 65. Perlamar Ltd Business Overview Table 66. Perlamar Ltd Radiopharmaceutical Transport Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Perlamar Ltd Radiopharmaceutical Transport Service Product Portfolio Table 68. Perlamar Ltd Recent Development Table 69. Isotopes Company Information Table 70. Isotopes Business Overview Table 71. Isotopes Radiopharmaceutical Transport Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Isotopes Radiopharmaceutical Transport Service Product Portfolio Table 73. Isotopes Recent Development Table 74. Global Airfreight International Company Information Table 75. Global Airfreight International Business Overview Table 76. Global Airfreight International Radiopharmaceutical Transport Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Global Airfreight International Radiopharmaceutical Transport Service Product Portfolio Table 78. Global Airfreight International Recent Development Table 79. Ameriflight Company Information Table 80. Ameriflight Business Overview Table 81. Ameriflight Radiopharmaceutical Transport Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Ameriflight Radiopharmaceutical Transport Service Product Portfolio Table 83. Ameriflight Recent Development Table 84. SWAN Isotopen AG Company Information Table 85. SWAN Isotopen AG Business Overview Table 86. SWAN Isotopen AG Radiopharmaceutical Transport Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. SWAN Isotopen AG Radiopharmaceutical Transport Service Product Portfolio Table 88. SWAN Isotopen AG Recent Development Table 89. Medi-Ops Company Information Table 90. Medi-Ops Business Overview Table 91. Medi-Ops Radiopharmaceutical Transport Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Medi-Ops Radiopharmaceutical Transport Service Product Portfolio Table 93. Medi-Ops Recent Development Table 94. Crisago Company Information Table 95. Crisago Business Overview Table 96. Crisago Radiopharmaceutical Transport Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Crisago Radiopharmaceutical Transport Service Product Portfolio Table 98. Crisago Recent Development Table 99. Yantai Dalong Logistics Co., Ltd. Company Information Table 100. Yantai Dalong Logistics Co., Ltd. Business Overview Table 101. Yantai Dalong Logistics Co., Ltd. Radiopharmaceutical Transport Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Yantai Dalong Logistics Co., Ltd. Radiopharmaceutical Transport Service Product Portfolio Table 103. Yantai Dalong Logistics Co., Ltd. Recent Development Table 104. Sinotau Pharmaceutical Group Company Information Table 105. Sinotau Pharmaceutical Group Business Overview Table 106. Sinotau Pharmaceutical Group Radiopharmaceutical Transport Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Sinotau Pharmaceutical Group Radiopharmaceutical Transport Service Product Portfolio Table 108. Sinotau Pharmaceutical Group Recent Development Table 109. Ichimiya Transport Company Information Table 110. Ichimiya Transport Business Overview Table 111. Ichimiya Transport Radiopharmaceutical Transport Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Ichimiya Transport Radiopharmaceutical Transport Service Product Portfolio Table 113. Ichimiya Transport Recent Development Table 114. Transnuclear Company Information Table 115. Transnuclear Business Overview Table 116. Transnuclear Radiopharmaceutical Transport Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Transnuclear Radiopharmaceutical Transport Service Product Portfolio Table 118. Transnuclear Recent Development Table 119. SK Group Company Information Table 120. SK Group Business Overview Table 121. SK Group Radiopharmaceutical Transport Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. SK Group Radiopharmaceutical Transport Service Product Portfolio Table 123. SK Group Recent Development Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Radiopharmaceutical Transport Service Product Image Figure 2. Global Radiopharmaceutical Transport Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceutical Transport Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Radiopharmaceutical Transport Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Short-half-life Radionuclide Transport Image Figure 8. Long-half-life Radionuclide Transport Image Figure 9. Global Radiopharmaceutical Transport Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Radiopharmaceutical Transport Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Radiopharmaceutical Transport Service Sales Value Share by Type (2021-2032) Figure 12. Radiopharmaceutical Manufacturers Image Figure 13. Hospitals and Medical Institutions Image Figure 14. Others Image Figure 15. Global Radiopharmaceutical Transport Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Radiopharmaceutical Transport Service Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Radiopharmaceutical Transport Service Sales Value Share by Application (2021-2032) Figure 18. Global Radiopharmaceutical Transport Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Radiopharmaceutical Transport Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Radiopharmaceutical Transport Service Sales Value (2021-2032) & (US$ Million) Figure 21. North America Radiopharmaceutical Transport Service Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Radiopharmaceutical Transport Service Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Radiopharmaceutical Transport Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Radiopharmaceutical Transport Service Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Radiopharmaceutical Transport Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Radiopharmaceutical Transport Service Sales Value (2021-2032) & (US$ Million) Figure 27. South America Radiopharmaceutical Transport Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Radiopharmaceutical Transport Service Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Radiopharmaceutical Transport Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Short-half-life Radionuclide Transport
  • Long-half-life Radionuclide Transport
Applications
  • Radiopharmaceutical Manufacturers
  • Hospitals and Medical Institutions
  • Others
Companies covered
  • AirNet II
  • Circle Express
  • Life Couriers
  • MNX Global Logistics
  • Kalitta Charters
  • Perlamar Ltd
  • Isotopes
  • Global Airfreight International
  • Ameriflight
  • SWAN Isotopen AG
  • Medi-Ops
  • Crisago
  • Yantai Dalong Logistics Co., Ltd.
  • Sinotau Pharmaceutical Group
  • Ichimiya Transport
  • Transnuclear
  • SK Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Radiopharmaceutical Transport Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Radiopharmaceutical Transport Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Radiopharmaceutical Transport Service Market Dynamics
  1. 2.1 Radiopharmaceutical Transport Service Industry Trends
  2. 2.2 Radiopharmaceutical Transport Service Industry Drivers
  3. 2.3 Radiopharmaceutical Transport Service Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceutical Transport Service Industry Restraints
3 Radiopharmaceutical Transport Service Market by Company
  1. 3.1 Global Radiopharmaceutical Transport Service Company Revenue Ranking in 2025
  2. 3.2 Global Radiopharmaceutical Transport Service Revenue by Company (2021-2026)
  3. 3.3 Global Radiopharmaceutical Transport Service Company Ranking (2024-2026)
  4. 3.4 Global Radiopharmaceutical Transport Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Radiopharmaceutical Transport Service Company Product Type and Application
  6. 3.6 Global Radiopharmaceutical Transport Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Radiopharmaceutical Transport Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Radiopharmaceutical Transport Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Radiopharmaceutical Transport Service Market by Type
  1. 4.1 Radiopharmaceutical Transport Service Type Introduction
  2. 4.1.1 Short-half-life Radionuclide Transport
  3. 4.1.2 Long-half-life Radionuclide Transport
  4. 4.2 Global Radiopharmaceutical Transport Service Sales Value by Type
  5. 4.2.1 Global Radiopharmaceutical Transport Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Radiopharmaceutical Transport Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Radiopharmaceutical Transport Service Sales Value Share by Type (2021-2032)
5 Radiopharmaceutical Transport Service Market by Application
  1. 5.1 Radiopharmaceutical Transport Service Application Introduction
  2. 5.1.1 Radiopharmaceutical Manufacturers
  3. 5.1.2 Hospitals and Medical Institutions
  4. 5.1.3 Others
  5. 5.2 Global Radiopharmaceutical Transport Service Sales Value by Application
  6. 5.2.1 Global Radiopharmaceutical Transport Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Radiopharmaceutical Transport Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Radiopharmaceutical Transport Service Sales Value Share by Application (2021-2032)
6 Radiopharmaceutical Transport Service Regional Value Analysis
  1. 6.1 Global Radiopharmaceutical Transport Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Radiopharmaceutical Transport Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Radiopharmaceutical Transport Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Radiopharmaceutical Transport Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Radiopharmaceutical Transport Service Sales Value (2021-2032)
  7. 6.3.2 North America Radiopharmaceutical Transport Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Radiopharmaceutical Transport Service Sales Value (2021-2032)
  10. 6.4.2 Europe Radiopharmaceutical Transport Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Radiopharmaceutical Transport Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Radiopharmaceutical Transport Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Radiopharmaceutical Transport Service Sales Value (2021-2032)
  16. 6.6.2 South America Radiopharmaceutical Transport Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Radiopharmaceutical Transport Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Radiopharmaceutical Transport Service Sales Value Share by Country, 2025 VS 2032
7 Radiopharmaceutical Transport Service Country-level Value Analysis
  1. 7.1 Global Radiopharmaceutical Transport Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Radiopharmaceutical Transport Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Radiopharmaceutical Transport Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Radiopharmaceutical Transport Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Radiopharmaceutical Transport Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Radiopharmaceutical Transport Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Radiopharmaceutical Transport Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AirNet II
  2. 8.1.1 AirNet II Company Information
  3. 8.1.2 AirNet II Business Overview
  4. 8.1.3 AirNet II Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AirNet II Radiopharmaceutical Transport Service Product Portfolio
  6. 8.1.5 AirNet II Recent Developments
  7. 8.2 Circle Express
  8. 8.2.1 Circle Express Company Information
  9. 8.2.2 Circle Express Business Overview
  10. 8.2.3 Circle Express Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Circle Express Radiopharmaceutical Transport Service Product Portfolio
  12. 8.2.5 Circle Express Recent Developments
  13. 8.3 Life Couriers
  14. 8.3.1 Life Couriers Company Information
  15. 8.3.2 Life Couriers Business Overview
  16. 8.3.3 Life Couriers Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Life Couriers Radiopharmaceutical Transport Service Product Portfolio
  18. 8.3.5 Life Couriers Recent Developments
  19. 8.4 MNX Global Logistics
  20. 8.4.1 MNX Global Logistics Company Information
  21. 8.4.2 MNX Global Logistics Business Overview
  22. 8.4.3 MNX Global Logistics Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 MNX Global Logistics Radiopharmaceutical Transport Service Product Portfolio
  24. 8.4.5 MNX Global Logistics Recent Developments
  25. 8.5 Kalitta Charters
  26. 8.5.1 Kalitta Charters Company Information
  27. 8.5.2 Kalitta Charters Business Overview
  28. 8.5.3 Kalitta Charters Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kalitta Charters Radiopharmaceutical Transport Service Product Portfolio
  30. 8.5.5 Kalitta Charters Recent Developments
  31. 8.6 Perlamar Ltd
  32. 8.6.1 Perlamar Ltd Company Information
  33. 8.6.2 Perlamar Ltd Business Overview
  34. 8.6.3 Perlamar Ltd Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Perlamar Ltd Radiopharmaceutical Transport Service Product Portfolio
  36. 8.6.5 Perlamar Ltd Recent Developments
  37. 8.7 Isotopes
  38. 8.7.1 Isotopes Company Information
  39. 8.7.2 Isotopes Business Overview
  40. 8.7.3 Isotopes Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Isotopes Radiopharmaceutical Transport Service Product Portfolio
  42. 8.7.5 Isotopes Recent Developments
  43. 8.8 Global Airfreight International
  44. 8.8.1 Global Airfreight International Company Information
  45. 8.8.2 Global Airfreight International Business Overview
  46. 8.8.3 Global Airfreight International Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Global Airfreight International Radiopharmaceutical Transport Service Product Portfolio
  48. 8.8.5 Global Airfreight International Recent Developments
  49. 8.9 Ameriflight
  50. 8.9.1 Ameriflight Company Information
  51. 8.9.2 Ameriflight Business Overview
  52. 8.9.3 Ameriflight Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ameriflight Radiopharmaceutical Transport Service Product Portfolio
  54. 8.9.5 Ameriflight Recent Developments
  55. 8.10 SWAN Isotopen AG
  56. 8.10.1 SWAN Isotopen AG Company Information
  57. 8.10.2 SWAN Isotopen AG Business Overview
  58. 8.10.3 SWAN Isotopen AG Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 SWAN Isotopen AG Radiopharmaceutical Transport Service Product Portfolio
  60. 8.10.5 SWAN Isotopen AG Recent Developments
  61. 8.11 Medi-Ops
  62. 8.11.1 Medi-Ops Company Information
  63. 8.11.2 Medi-Ops Business Overview
  64. 8.11.3 Medi-Ops Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Medi-Ops Radiopharmaceutical Transport Service Product Portfolio
  66. 8.11.5 Medi-Ops Recent Developments
  67. 8.12 Crisago
  68. 8.12.1 Crisago Company Information
  69. 8.12.2 Crisago Business Overview
  70. 8.12.3 Crisago Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Crisago Radiopharmaceutical Transport Service Product Portfolio
  72. 8.12.5 Crisago Recent Developments
  73. 8.13 Yantai Dalong Logistics Co., Ltd.
  74. 8.13.1 Yantai Dalong Logistics Co., Ltd. Company Information
  75. 8.13.2 Yantai Dalong Logistics Co., Ltd. Business Overview
  76. 8.13.3 Yantai Dalong Logistics Co., Ltd. Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Yantai Dalong Logistics Co., Ltd. Radiopharmaceutical Transport Service Product Portfolio
  78. 8.13.5 Yantai Dalong Logistics Co., Ltd. Recent Developments
  79. 8.14 Sinotau Pharmaceutical Group
  80. 8.14.1 Sinotau Pharmaceutical Group Company Information
  81. 8.14.2 Sinotau Pharmaceutical Group Business Overview
  82. 8.14.3 Sinotau Pharmaceutical Group Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sinotau Pharmaceutical Group Radiopharmaceutical Transport Service Product Portfolio
  84. 8.14.5 Sinotau Pharmaceutical Group Recent Developments
  85. 8.15 Ichimiya Transport
  86. 8.15.1 Ichimiya Transport Company Information
  87. 8.15.2 Ichimiya Transport Business Overview
  88. 8.15.3 Ichimiya Transport Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Ichimiya Transport Radiopharmaceutical Transport Service Product Portfolio
  90. 8.15.5 Ichimiya Transport Recent Developments
  91. 8.16 Transnuclear
  92. 8.16.1 Transnuclear Company Information
  93. 8.16.2 Transnuclear Business Overview
  94. 8.16.3 Transnuclear Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Transnuclear Radiopharmaceutical Transport Service Product Portfolio
  96. 8.16.5 Transnuclear Recent Developments
  97. 8.17 SK Group
  98. 8.17.1 SK Group Company Information
  99. 8.17.2 SK Group Business Overview
  100. 8.17.3 SK Group Radiopharmaceutical Transport Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 SK Group Radiopharmaceutical Transport Service Product Portfolio
  102. 8.17.5 SK Group Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst